Showing results (91-100 of 149) with videos related to
Sort By:
Pageof 15
Schizophrenia Research|July 5, 2014
Efficacy and safety of aripiprazole in Chinese Han schizophrenia subjects: a randomized, double-blind, active parallel-controlled, multicenter clinical trialHuafang Li, Jianfeng Luo, Chuanyue Wang, et al.Pharmacogenomics|October 24, 2006
Polymorphisms of the ABCB1 gene are associated with the therapeutic response to risperidone in Chinese schizophrenia patientsQinghe Xing, Rui Gao, Huafang Li, et al.Analytical Chemistry|June 2, 2006
Altered levels of acute phase proteins in the plasma of patients with schizophreniaYifeng Yang, Chunling Wan, Huafang Li, et al.Biomedical Chromatography : BMC|June 27, 2013
Determination of the stress biomarker corticosterone in serum of tumor-bearing mice by surrogate-based liquid chromatography-tandem mass spectrometryLei Kang, Tao Jiang, Xinxing Ge, et al.Journal of Child and Adolescent Psychopharmacology|August 2, 2019
The Impact of Placebo Response Rates on Clinical Trial Outcome: A Systematic Review and Meta-Analysis of Antidepressants in Children and Adolescents with Major Depressive DisorderYanfei Li, Jihan Huang, Yingchun He, et al.International Journal of Psychiatry in Clinical Practice|October 3, 2012
A randomized, double-blind, double-dummy, multicenter, controlled trial on brotizolam intervention in outpatients with insomniaXiaolei Yan, Shuzhen Huang, Cui Ma, et al.Expert Opinion on Investigational Drugs|December 6, 2023
Safety, tolerability, and pharmacokinetics of JX11502MA in Chinese healthy subjects: a first-in-human, randomized, double-blind, placebo-controlled study following single-dose administrationYimin Yu, Jingjing He, Zhiwei Huang, et al.Neuropsychiatric Disease and Treatment|January 27, 2016
Safety and efficacy of paliperidone extended-release in Chinese patients with schizophrenia: a 24-week, open-label extension of a randomized, double-blind, placebo-controlled studyHongyan Zhang, Huafang Li, Yanning Liu, et al.Frontiers in Psychiatry|October 17, 2022
Plasma metabolomics of schizophrenia with cognitive impairment: A pilot studyYihe Jiang, Xiujia Sun, Miaowen Hu, et al.The Journal of Clinical Psychiatry|March 6, 2015
The feasibility of utilizing plasma MiRNA107 and BACE1 messenger RNA gene expression for clinical diagnosis of amnestic mild cognitive impairmentTao Wang, Kewei Chen, Huafang Li, et al.Pageof 15